The distinction between mild pathogenic mtDNA mutations and population polymorphisms can be ambiguous because both are homoplasmic, alter conserved functions, and correlate with disease. One possible explanation for this ambiguity is that the same variant may have different consequences in different contexts. The NADH dehydrogenase subunit 1 (ND1) nucleotide 3394 T > C (Y30H) variant is such a case. This variant has been associated with Leber hereditary optic neuropathy and it reduces complex I activity and cellular respiration between 7% and 28% on the Asian B4c and F1 haplogroup backgrounds. However, complex I activity between B4c and F1 mtDNAs, which harbor the common 3394T allele, can also differ by 30%. In Asia, the 3394C variant is most commonly associated with the M9 haplogroup, which is rare at low elevations but increases in frequency with elevation to an average of 25% of the Tibetan mtDNAs (odds ratio = 23.7). In high-altitude Tibetan and Indian populations, the 3394C variant occurs on five different macrohaplogroup M haplogroup backgrounds and is enriched on the M9 background in Tibet and the C4a4 background on the Indian Deccan Plateau (odds ratio = 21.9). When present on the M9 background, the 3394C variant is associated with a complex I activity that is equal to or higher than that of the 3394T variant on the B4c and F1 backgrounds. Hence, the 3394C variant can either be deleterious or beneficial depending on its haplogroup and environmental context. Thus, this mtDNA variant fulfills the criteria for a common variant that predisposes to a "complex" disease.
The distinction between mild pathogenic mtDNA mutations and population polymorphisms can be ambiguous because both are homoplasmic, alter conserved functions, and correlate with disease. One possible explanation for this ambiguity is that the same variant may have different consequences in different contexts. The NADH dehydrogenase subunit 1 (ND1) nucleotide 3394 T > C (Y30H) variant is such a case. This variant has been associated with Leber hereditary optic neuropathy and it reduces complex I activity and cellular respiration between 7% and 28% on the Asian B4c and F1 haplogroup backgrounds. However, complex I activity between B4c and F1 mtDNAs, which harbor the common 3394T allele, can also differ by 30%. In Asia, the 3394C variant is most commonly associated with the M9 haplogroup, which is rare at low elevations but increases in frequency with elevation to an average of 25% of the Tibetan mtDNAs (odds ratio = 23.7). In high-altitude Tibetan and Indian populations, the 3394C variant occurs on five different macrohaplogroup M haplogroup backgrounds and is enriched on the M9 background in Tibet and the C4a4 background on the Indian Deccan Plateau (odds ratio = 21.9). When present on the M9 background, the 3394C variant is associated with a complex I activity that is equal to or higher than that of the 3394T variant on the B4c and F1 backgrounds. Hence, the 3394C variant can either be deleterious or beneficial depending on its haplogroup and environmental context. Thus, this mtDNA variant fulfills the criteria for a common variant that predisposes to a "complex" disease.
adaptation | hypoxia | OXPHOS | complex disease T he line demarcating pathogenic mtDNA polypeptide mutations from benign population polymorphisms has become increasingly blurred (1, 2) . Classic pathogenic mtDNA mutations are recent, heteroplasmic, change highly conserved amino acids, and cause biochemical changes in mitochondrial functions in transmitochondrial cybrids (3, 4) . However, population-specific groups of related mtDNA haplotypes (haplogroups) are commonly founded by amino acid substitution variants that change amino acids that can be conserved throughout much of the animal kingdom. This anomaly has led to the hypothesis that certain mtDNA variants are adaptive in specific environments and become enriched by natural selection. However, these same mtDNA haplogroups can be associated with various degenerative diseases in other contexts (5-7).
The first inherited mtDNA disease mutation was a missense mutation in the mtDNA ND4 gene at nucleotide 11778 G > A arginine 340 to histidine (R340H) that causes the midlife blindness Leber hereditary optic neuropathy (LHON) (8) . Subsequently, several mtDNA mutations were found to cause LHON in Europeans: NADH dehydrogenase subunit 1 (ND1) G3460A (A52T) (9), ND6 T14484C (M64V) (10) , and ND6 G14459A (A72V) (11) . The ND6 14459A mutation generates the most severe complex I defect (12) and causes LHON when heteroplasmic but dystonia when homoplasmic (11, 13) . The remaining mutations cause milder complex I defects (14) (15) (16) (17) (18) and cause LHON when near homoplasmic (8) (9) (10) . For the milder LHON mutations (11778A, 3460A, 14484C) the penetrance of blindness is increased when the mutations arise on mtDNA haplogroup J (19) (20) (21) (22) .
In addition to the common European LHON variants (11778A, 3460A, 14484C, and 14459A), a large number of rarer mtDNA variants have also been associated with LHON, either together with the 3460, 11778, and 14484 mutations or in isolation. One such variant is a T > C mutation found at nucleotide 3394 in the ND1 gene, which changes an evolutionarily conserved tyrosine (Y) 30 to histidine (H) (Y30H). This variant was first reported associated with LHON in a survey of 47 European LHON pedigrees, where four patients harbored the 3394C variant, 8.5% of LHON pedigrees vs. 1.1% of controls. However, one of the 3394C patients also harbored the 11778A mutation and the other three the 14484C mutation, all on haplogroup J (21). The 3394C variant was found in another European pedigree in association with the 14484C mutation and haplogroup J (23) .
In Chinese studies, the 3394C variant was reported in four pedigrees in association with the 11778A mutation and haplogroup M9a (24) . However, in four other Chinese LHON patients the 3394C variant was the only potentially pathogenic mutation, occurring on haplogroups D4b and M9a (25) . Therefore, the 3394C variant lies at the interface between a pathogenic and a polymorphic variant and permits addressing the question: What level of mitochondrial complex I defect is necessary to produce LHON?
The mtDNA has a high mutation rate, but the most deleterious mtDNA mutations are removed by intraovarian selection (26, 27) . As a result, mtDNA variants, which mildly perturb mitochondrial bioenergetics, are continuously being introduced into the population. Although some of these variants cause significant mitochondrial defects and disease (1), milder variants can increase in frequency in certain populations, suggesting that they may be advantageous in particular local environments. Adaptive mtDNA missense mutations should change a functionally important amino acid, be enriched in a particular population, appear on several different mtDNA backgrounds, initiate mtDNA haplogroup lineages in particular environmental contexts, correlate in frequency with the intensity of the selective environmental condition, and significantly affect mitochondrial function. If the mutation is also deleterious in another context, then the variant would have been enriched in opposition to purifying selection, which would be unlikely to occur by genetic drift. Rather, the environment must have nullified the variant's adverse effects (5) (6) (7) .
In Asia, the 3394C variant appears to be such a context-specific deleterious or adaptive mtDNA variant. Although it has been reported to cause LHON in low-altitude populations, it is enriched in high-altitude Tibetan and Indian populations, particularly in association with macrohaplogroup M haplogroups M9 and C4a4, respectively. Furthermore, the 3394C variant is associated with reduced complex I activity on B4c and F1 haplogroups but high complex I activity on haplogroup M9. Therefore, the 3394C variant appears to be deleterious in one mtDNA and environmental context but beneficial in another.
Results
Biochemical Alterations Associated with the T3394C Variant. The ND1 nucleotide T3394C Y30H variant changes an amino acid that is conserved in 99% (939 of 946) of mammalian mtDNAs and thus should be functionally important. To determine if there is a biochemical defect associated with the 3394C variant, we screened 390 Southern California Han Chinese to identify individuals whose mtDNAs harbored the 3394T and the 3394C variants on the same haplogroup background and found both alleles associated with the B4c and F1 haplogroups ( Table 1 and Table  S1 ). We then transferred the 3394T and 3394C mtDNAs on to a uniform nuclear DNA (nDNA) background by fusion of platelets from the subjects to 143B(TK − ) ρ o cells (4) . Cybrid fusions were performed for two subjects with the 3394C B4c mtDNA, two subjects with the 3394T B4c mtDNA, one with the 3394C F1 mtDNA, and two with the 3394T F1 mtDNA. The mtDNAs from these subjects and a number of their transmitochondrial cybrid clones were completely sequenced (Tables S2-S4) .
To detect the relatively subtle complex I defect expected for the ND1 T3394C mutation, we developed a highly precise complex I assay using alamethicin permeabilized mitochondria. To test the precision of this system, we analyzed the complex I activity of one of the B4c 3394T cybrid clones, which we found had acquired a de novo missense mutation in the ND1 gene at nucleotide T3515C (L70P), which disrupts a transmembrane helix (Table S3 ). Because the 3515T vs. 3515C clones were derived from the same B4c 3394T subject, their mtDNA sequences were otherwise identical. The nucleotide 3515C (L70P) missense mutation reduced the complex I specific activity by 65% (P < 0.0001). The extremely low P value indicates the ultra-low variance around the mean of the multiple determinations made for the two cell lines. This finding confirms the reliability of both our cybrid technique and complex I assay (Fig. 1A) .
Applying this analysis to the B4c subjects revealed that the 3394C variant was associated with a 28% reduction in complex I activity relative to the 3394T variant (P = 0.0006). On the F1 background, the 3394C variant was associated with a 15% reduction in complex I activity (P = 0.047) (Fig. 1A) . When measuring cellular O 2 consumption using the Oroboros respirometer and site I substrates (Fig. 1B) , the basal respiration rate associated with the 3394C B4c mtDNAs was 17.3% less than the 3394T B4c rate (P = 0.04) and the uncoupled rate was reduced 7.3% (P = 0.016). Similarly, the basal rate of the 3394C F1 mtDNAs was 12.3% less that the 3394T F1 mtDNAs (P = 0.092), but the uncoupled rate was reduced 16.5% (P = 0.006) (Fig. 1B) . Therefore, 3394C reduces both complex I activity and NADH-linked respiration, thus confirming that it can contribute to the pathophysiology of LHON. Although the above studies showed that the 3394C variant can inhibit complex I activity in Southern California Han Chinese, haplogroup M9, which contains the 3394C variant, was found in 2.2% of the population (8 of 390) ( Table 1 ). This result contrasts with a frequency of the 3394C allele associated with F1 and B4 haplogroups of 0.1-0.3% (Table  S1 ). This finding raised the question: Why should the 3394C variant be maintained in the Chinese population on haplogroup M9 at polymorphic frequencies? The answer to this question unexpectedly came from our Chinese population studies, which revealed that M9 with the 3394C variant is strongly enriched in Tibetans.
Analysis of Tibetan Haplogroup Distribution. In two independent Tibetan expeditions, we collected samples from six Tibetan villages located above 3,000-m elevation. Expedition sample 1 recruited 216 individuals and expedition sample 2, the earlier of the two, recruited 73 individuals (28) ( Table 1) . These high-altitude samples were compared with three low-altitude Chinese samples: the 390 Han Chinese living in Southern California, 137 subjects from southwestern (SW) China, and 1,117 from Taiwan ( Table 1 ). The mtDNA haplogroups of the Tibetan and lowaltitude Chinese samples were determined by analyzing restriction fragment-length polymorphisms (RFLP), screening for additional informative variants, sequencing the hypervariable section I (HVS I) of the mtDNA control region, and sequencing the entire mtDNAs of representative mtDNAs (see SI Materials and Methods). Tibetan sample 1 mtDNAs. Tibetan sample 1 was found to encompass 14 haplogroups ( Fig. 2A , Table 1, and Tables S5 and S6 ). All of these haplogroups have previously been reported in Asians, with the exception of mtDNA haplogroups M14, M15, and U1. All Asian haplogroups can be grouped into two Asian macrohaplogroups, M and N. Tibetan sample 1 macrohaplogroup N mtDNAs include haplogroups A, B, F, and U (26% of subjects); macrohaplogroup M mtDNAs included C, D, G, M8, M9, M13, and the rare M haplogroups M2, M11, M14, and M15 (74% of subjects) (see SI Results). Tibetan sample 2 mtDNAs. Tibetan sample 2 (28) was found to encompass 10 major haplogroups ( Fig. 2A , Table 1, and Tables S7 and  S8) . Of these haplogroups, about 30% were N and 70% were M.
Analysis of Low-Altitude Asian mtDNA Haplogroups. The Southern California Han Chinese sample encompassed 17 major haplogroups ( Fig. 2B and Table 1 ) and 25 lineages (Table S1 ). The SW China Han Chinese sample encompassed 14 mtDNA haplogroups (Fig. 2B , Table 1, and Tables S9 and S10 ) and the Taiwan Han Chinese sample encompassed 13 mtDNA haplogroups and subhaplogroups ( Fig. 2B and Table 1 ), all of which have been previously described (29) (30) (31) (32) (33) . The average macrohaplogroup distribution of the low-altitude populations was N = 49% and M = 51% (Table 1) .
Altitude Association of the M9 Haplogroup and the T3394C Variant.
Comparison of the haplogroup frequency distribution of the two high-altitude-adapted Tibetan samples with the three low-altitude-adapted Asian samples revealed a striking increase in frequency the Tibetan haplogroup M9. The average M9 frequency of the low-altitude Asian populations was 1.7% (range 1.4-2.9%). In contrast, the M9 frequency of our two Tibetan populations was 25.3% ( Fig. 2 and Table 1 ). Thus, there is a highly significant association between M9 and Tibetans, with the odds ratio (OR) of observing the M9 haplogroup in Tibetan sample 1 being 12.5-times higher than that for SW China sample, and OR being 19.5-times higher between the two Tibetan samples and three low-altitude Asian populations (Pearson χ 2 test, P < 0.001) ( Table 2 and Fig. S1A ).
An independent survey of 680 Tibetan mtDNAs from 1,500 m and up (34) also revealed an elevated frequency of M9 of 16.4%. Comparison of the combined three Tibetan samples [samples 1 + 2 + Zhao et al. (34) ] vs. all non-Tibetan samples both examined here and in published reports (mean M9 frequency of 0.6%) gave an OR = 23.7 (Table 2 and Fig. S1A) . Hence, the M9 mtDNA haplogroup is significantly enriched in high-altitude Tibetan populations.
In addition to the defining M9 variant in ND2 nucleotide G4491A (V8I), sequence analysis of six Tibetan M9 mtDNAs revealed that all contained the ND1 3394C (Y30H) variant. Further screening of Tibetan mtDNAs for the 3394C variant using the associated HaeIII restriction-site variant revealed that all of the M9 mtDNAs harbored the 3394C, as did one of the 27 D4 and one of the seven G3b mtDNAs from Tibetan sample 1 ( Fig. 3A and Tables S6 and S11). The OR of finding the 3394C variant among Tibetan samples 1 and 2 vs. our three low-altitude populations was 17.9-times higher and that for all three Tibetan samples [1, 2 and Zhao et al. (34)] vs. the three Han Chinese samples was 14.7 (Table 2 and Fig. S1B ).
An independent study of Indian Tibeto-Burman linguist populations revealed the 3394C variant in 21 M9, 1 M11a, and 12 C4a4 mtDNAs. All of the M9, the one M11a, and two of the C4a4 3394C mtDNAs were observed in several tribes living in Northeastern India adjacent to Tibet. The remaining 10 C4a4 3394C mtDNAs were found in the Jenu Kuruba tribe living on the Deccan plateau at 1500-1750 m altitude (35) (Table S11) . Combining these results with ours revealed that the 3394C variant was observed in populations at 1,500 m or above on five different mtDNA haplogroups, and that all of the M9 haplogroup mtDNAs in the Himalaya and 83% of the C4a4 haplogroup mtDNAs in the Deccan plateau harbor the 3394C variant. Thus, the 3394C variant has arisen multiple times and been enriched on two different mtDNA backgrounds in two independent, higher-altitude populations. Combining all available data revealed that above 1,500 m the 3394C variant is 21.9-times more likely at high altitude than low (Table 2 and Fig. S1B ).
To further verify that the M9 haplogroup and the 3394C variant were enriched by altitude, we calculated the frequencies of M9 and 3394C for each Tibetan village observed in our samples 1 and 2 and by Zhao et al. (34) . This finding revealed that the frequency of both the M9 haplogroup (R 2 = 0.40) and the 3394C variant (R 2 = 0.31) increased as the altitude of the village sampled increased (Fig. 3 B and C and Table S12 ).
Although the ND1 Y30 amino acid is highly conserved among mammals, it is variant among Macaca mulatta and Macaca sylvanus (Y30H), consistent with M. mulatta having formerly been found in southern China and Tibet at elevations up to 3,000 m (36) . Similarly, Theropithecus gelada is Y30C and this primate lives in the Ethiopia and Eritrea highlands between 2,000 and 5,000 m. Hence, variation in ND1 Y30 can be associated with high altitude in other primates as well as humans (Table S13) .
Biochemical Consequences of the 3394C Variant on the M9 Haplogroup.
To determine why the 3394C variant might be enriched in Tibetans on the M9 haplogroup, we prepared transmitochondrial cybrids from southern Californian Han Chinese harboring M9-3394C mtDNAs (Table S2) . Surprisingly, the complex I-specific activity and basal NADH-linked respiration of the M9 cybrids with the 3394C allele were much higher than those activities of either the B4c or the F1 cybrids with the 3394C allele and equal to or higher than the complex I activity of the B4c and F1 cybrids with the wildtype 3394T allele (Fig. 1) . Moreover, we could not find any M9 mtDNAs with the 3394T allele, suggesting that the T allele may be incompatible with the M9 mtDNA background. Finally, every time that the 3394C allele was found at high altitude, it occurred on a macrohaplogroup M mtDNA (M9, C4a4, D4, and G3b).
Discussion
The 3394C variant provides evidence that a mtDNA allele can be deleterious in one context but advantageous in another. At low altitude the 3394C variant increases the risk of LHON (14) (15) (16) (17) (18) , which is consistent with its 15-28% reduction in complex I-specific activity and a 7-17% reduction in maximum respiration rate.
However, mtDNA background is a major contributing factor to the complex I activity associated with the 3394C variant, with greater differences being found between different haplogroups with the same ND1 allele (3394T) than were found within the same mtDNA haplogroup with different 3394 alleles (T vs. C). Therefore, both individual sequence variants and haplotypes influence mitochondrial function. That these differences can be phenotypically relevant is confirmed by the report that haplogroup F mtDNAs are associated with increased risk of developing diabetes (37), and these cybrids had the lowest complex I activities.
The 3394C variant fulfills all of the criteria expected for an adaptive variant enriched by high altitude. The 3394C variant is enriched in both Tibetan and the Indian subcontinent populations living above 1,500 m, OR = 21.9; it has been found on five different haplogroups above 1,500 m, with M9 predominating in the Himalayas and C4a4 in the Deccan plateau. Variants at amino acid ND1 30Y are found in other high-altitude primates. Finally, the variant is associated with LHON in low-altitude populations, and if this were true at high altitudes blindness would be common in Tibetans and the mutant allele would have had to be enriched by drift in the face of natural selection.
The 3394C variant is only found on macrohaplogroup M mtDNAs at high altitude and macrohaplogroup M mtDNAs themselves increase in frequency with altitude, the ratio of N to M mtDNAs for all three low elevation Asian populations being 49:51; for Tibetan samples 1 and 2 it was 26:74 and 30:70, respectively. Therefore, both the 3394C variant and haplogroup M mtDNAs are enriched at higher elevations. Although the 3394C variant on macrohaplogroup N B4 and F1 mtDNAs was associated with reduced complex I activity, the 3394C variant on the macrohaplogroup M mtDNA M9 had the highest complex I activity. Hence, the functional benefit of the 3394C allele is only manifested in the context of macrohaplogroup M. Still, haplogroup background is insufficient to explain all of the phenotypic consequences of the 3394C variant, because the 3394C variant on the M9 haplogroup has been associated with LHON in low-altitude Asian populations (24, 25) . Thus, environment must also modulate the phenotypic consequence of the 3394C variant.
The deleterious consequences of the 3394C variant when occurring on macrohaplogroup N may be the result of most macrohaplogroup N mtDNAs harboring two additional mtDNA amino acid variants, ND3 (nucleotide A10398C, A114T) and ATP6 (nucleotide G8701A, A59T), which macrohaplogroup M lacks (1, 38) . The nucleotide 10398 and nucleotide 8701 variants have been correlated with alterations in mitochondrial matrix calcium and pH (39) . European haplogroup J, a derivative of macrohaplogroup N, lacks the nucleotide 10398 variant but has the additional amino acid-altering variants, nucleotide 13708 in ND5 and nucleotides 14798 or 15257 in cytochrome b.
The environmental factors that render the 3394C variant on M9 deleterious at low altitude remain unknown (25) , although reduced oxygen tension is one likely factor. Physiological alterations have been observed in high-altitude Tibetan, Peruvian Andean Native Americans, and India subcontinent populations (40, 41) , which may be the result of changes in mitochondrial physiology (42, 43) . For example, an alteration in complex I might increase mitochondrial reactive oxygen species production, which increases to toxic levels under high-but not lowoxygen tension. Alternatively, increased NADH/NAD + ratios could impede the tricarboxylic acid cycle, increasing succinate or fumarate levels which could strabilize hypoxia-inducible factors 1 and 2 (HIF-1, HIF-2) and increase adaptation to hypoxia (44) . The genes of the HIF-1 and -2 pathways have been found to be altered in Tibetan and Andean populations (45) (46) (47) (48) .
Whatever the interactions between the 3394C allele, macrohaplogroup M, and high altitude, it seems clear that the 3394C variant can be adaptive in some contexts but deleterious in others. Thus, genetic variants that alter bioenergetics, which most commonly occur in the mtDNA, may be the long-sought common genetic alleles that predispose to "complex" diseases.
Materials and Methods
Biochemical Analysis of the mtDNA ND1Y30H Variant. Preparation of 3394T vs. 3394C mtDNA cybrids. Cybrids were prepared by fusing subject blood platelets to human mtDNA-deficient (ρ Mitochondrial complex I (NADH: coenzyme Q 1 oxidoreductase) activity. Mitochondria were isolated by differential centrifugation and the pellets were resuspended in iso-osmotic solution and frozen. The mitochondria were permeabilized by incubation in assay buffer with alamethicin (40 μg/mL). Complex I was assayed using 25 μg of mitochondria, coenzyme q1, and NADH. NADH oxidation was monitored at 340 nm using a dual-beam spectrophotometer, with or without rotenone, and rotenone-sensitivity calculated (SI Materials and Methods).
The complex I assays of the B4c cybrids involved two independent subjects for each allele, encompassing eight and nine separate mitochondrial isolations from B4c 3394T and B4c 3394C clones, respectively. The B4c 3394T 3515C cybrid clone complex I was assayed six times.
The complex I activity of the F1a cybrid clones involved three separate mitochondrial isolations from a cybrid clone of the F1a 3394C subject, two mitochondrial isolations from a cybrid clone of one of the F1a 3394T subjects and one mitochondrial isolation from the cybrid clone of the other F1a 3394C subject. The results of 10 complex I assays were averaged for the three cybrid clones (see SI Results).
The mtDNA/nDNA ratios of all clones assayed for complex I activity were within 20% of the mean of the mtDNA/nDNA ratio of all clones and did not correlate with enzyme activities (SI Materials and Methods and Fig. S2 ). Cybrid oxygen consumption. O 2 consumption rates of 5 × 10 5 cells/mL were monitored in the Oroboros Oxygraph-2K in medium without serum at 37°C. Basal and uncoupled rates [0.4 μM carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) dissolved in DMSO] were monitored.
Population Sampling and Analysis. All sampled individuals could trace their ancestry through the maternal lineage back at least three generations. Samples were collected by informed consent consistent with National Institutes of Health guidelines and the provisions of the respective countries. mtDNA analysis. All nucleotide positions are reported relative to the Revised Cambridge Reference Sequence (50) . The mtDNA was amplified from whole blood in 22 overlapping PCR fragments, and each fragment subjected to digestion with 18 informative restriction endonucleases (28, 51) (SI Materials and Methods). The entire mtDNA was sequenced for 39 Tibetan mtDNAs Table S12 . and 18 SW China Han mtDNAs (SI Materials and Methods). The GenBank accession nos. are FJ748704-FJ748759. Sequence collections and analyses. The Tibetan mtDNA data from the RFPLs/HVS I analysis and the complete mtDNA sequence data were classified into haplogroups using the Mitomap Phylogeny (52) . In addition, the complete sequences of 7,088 human mtDNAs were downloaded from National Center for Biotechnology Information (NCBI) (May 2010). Statistical analysis used SAS (see SI Materials and Methods).
